A detailed history of Planning Capital Management Corp transactions in Nkarta, Inc. stock. As of the latest transaction made, Planning Capital Management Corp holds 35 shares of NKTX stock, worth $117. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 5 600.0%
Holding current value
$117
Previous $30,000 430.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$4.52 - $8.0 $135 - $240
30 Added 600.0%
35 $159,000
Q2 2024

Aug 12, 2024

BUY
$5.27 - $10.82 $26 - $54
5 New
5 $30,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $163M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.